Nasdaq Stockholm-listed Swedish Orphan Biovitrum (SOBI), a global biopharma company, is to acquire US-based Arthrosi Therapeutics, a clinical-stage biotech company focused on the development of therapy for gout and chronic kidney disease. Arthrosi was invested in and incubated by HK-listed Viva Biotech Holdings.
Under the terms of the agreement, Sobi will...
Colisée, a France-based European private-sector provider of support and care for the elderly and the fourth-largest private operator of nursing homes in Europe, has announced the signing of a lock-up agreement as part of a financial recapitalisation plan led by its lenders, said to include Blackstone and KKR, resulting in a change of ownership. As part of this process, EQT Infrastructure V and other shareholders are expected to exit their position.
EQT acquired a majority stake in Colisée in 2020 from IK Partners, attracted by the opportunity to grow the...
